Literature DB >> 6572081

Effects of prostaglandin E2 on fast and slow components of the response of the rat vas deferens to field stimulation.

J R Bedwani, P E Blanning.   

Abstract

1 The response of the rat vas deferens to field stimulation with single pulses is biphasic. The first, rapid component of the response is dominant at the prostatic end and is thought by some to be mediated by non-adrenergic, non-cholinergic neurotransmission. The second, slower component predominates at the epididymal end and has the usual properties associated with adrenergic responses. 2 Prostaglandin E2 (PGE2, 10(-8) to 10(-5) mol/l) inhibited the 'fast component' responses elicited by field stimulation of the prostatic vas from reserpine-treated rats. The prostaglandin was more potent in the presence of 1.25 than 2.5 mmol/lCa2+. 3 PGE2 (10(-7) to 10(-5) mol/l) had similar effects on prostatic preparations from normal rats, but was less active on these. 4 PGE2 (10(-9) to 10(-5)mol/l) did not inhibit the 'slow component' responses resulting from field stimulation of the epididymal vas but rather, at the two highest concentrations used (5 x 10(-6) and 10(-5) mol/l), potentiated them. These high concentrations of the prostaglandin also potentiated the contractions of the epididymal vas elicited by exogenous noradrenaline. 5 These effects of PGE2 on the two components of the response of the rat vas deferens are not as might be expected from its inhibitory effects on the 'typical' adrenergic neurotransmission in several other sympathetically-innervated tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572081      PMCID: PMC2044783          DOI: 10.1111/j.1476-5381.1983.tb09374.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

Review 1.  Basic mechanisms of prostaglandin action on autonomic neurotransmission.

Authors:  P Hedqvist
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

Review 2.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  Prostaglandin-induced neurotransmission failure in the field-stimulated, isolated vas deferens.

Authors:  P Hedqvist; U S Von Euler
Journal:  Neuropharmacology       Date:  1972-03       Impact factor: 5.250

4.  Influence of prostaglandins on autonomic responses.

Authors:  T Baum; A T Shropshire
Journal:  Am J Physiol       Date:  1971-11

5.  Biphasic mechanical response of the isolated vas deferens to nerve stimulation.

Authors:  G Swedin
Journal:  Acta Physiol Scand       Date:  1971-04

6.  Prostaglandin action on noradrenaline release and mechanical responses in the stimulated guinea pig vas deferens.

Authors:  P Hedqvist
Journal:  Acta Physiol Scand       Date:  1974-01

7.  Prostaglandin-versus alpha-adrenoceptor-mediated control of sympathetic neurotransmitter secretion in guinea-pig isolated vas deferens.

Authors:  L Stjärne
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

8.  An analysis of the anatomical basis for the mechanical response to motor nerve stimulation of the rat vas deferens.

Authors:  P G Anton; M E Duncan; J C McGrath
Journal:  J Physiol       Date:  1977-12       Impact factor: 5.182

9.  Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs.

Authors:  N Ambache; L P Dunk; J Verney; M A Zar
Journal:  J Physiol       Date:  1972-12       Impact factor: 5.182

10.  The rat anococcygeus muscle and its response to nerve stimulation and to some drugs.

Authors:  J S Gillespie
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more
  1 in total

1.  A comparison of the effects of exogenous and endogenous prostaglandins on fast and slow contractions of field-stimulated guinea-pig vas deferens.

Authors:  A M McKay; N L Poyser
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.